Search

everythinglearnresearchcommunity

for

Search:↓

Combining polymers and lipids may improve antioxidant delivery for wound healing, but practical challenges remain.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

The method effectively measures drug impact on DHT levels in prostate treatments.

Peptide hydrogels are promising for drug delivery and tissue repair in medicine.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Ginkgo biloba has high genetic diversity, useful for future breeding.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

N-oxides are important in medicine for improving drug properties and targeting.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

3D bioprinting is advancing rapidly, improving regenerative therapy and drug delivery.

A fungal enzyme was used to make compounds more soluble, aiding drug discovery and crop protection.

Certain bacteria from the Citrullus colocynthis plant may be a new source of antibiotics to fight drug-resistant diseases.

The rare cliff plant Oresitrophe rupifraga has diverse metabolites, with leaves rich in phenolic acids and rhizomes and bulblets high in terpenoids, aiding its growth and potential use.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Zebrafish can help study and develop treatments for hearing loss.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Polymer-based nanocarriers can improve acne treatment by delivering drugs through hair follicles more effectively.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.